Novartis AG develops and manufactures innovative medicines, with core research and development focused on oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic diseases. The company also operates an established medicines business that includes off-patent franchises. Novartis markets its products worldwide, with the United States accounting for nearly one-third of total revenue.